AbbVie | ABBV - أصول متداولة





أصول متداولة تغيير تاريخ
AbbVie USD 33.67B 140M 2026-06
Abbott USD 25.51B 488M 2026-03
ALKERMES USD 1.52B 164.26M 2026-06
Amgen USD 34.96B 3.49B 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Biogen USD 7.58B 278.7M 2026-09
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Coherus Biosciences USD 133.79M 72.25M 2026-06
Eisai JPY 883.01B 121.38B 2026-06
Eli Lilly USD 65.26B 591M 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
J&J USD 56.35B 3.42B 2026-09
Medtronic USD 24.39B 397M 2026-06
Merck USD 36.68B 1.66B 2026-06
Neurocrine Biosciences USD 1.64B 798.6M 2026-06
Novartis USD 27.35B 744M 2026-06
Pacira USD 615.21M 100.25M 2026-06
Perrigo USD 2.45B 260.7M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
UCB EUR 6.05B 733M 2025-12
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
United Therapeutics USD 3.48B 611.7M 2026-06
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06
Zoetis USD 6.36B 118M 2026-06